Recent evidence further supports its role in malignancy, whereby TNXB is indicated as one of the triple-evidenced genes, which exhibit aberrant methylation, differentially expressed and associated with somatic mutation, hence, displaying the superior predictive ability in cancer diagnosis and prognosis [73]. Here, TNXB is linked to cancer.